We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

1 Consumer Staples 21.66%
2 Healthcare 21%
3 Consumer Discretionary 11.38%
4 Communication Services 9.41%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WU icon
426
Western Union
WU
$2.57B
$22K ﹤0.01%
957
– –
HEI.A icon
427
HEICO Corp Class A
HEI.A
$35.5B
$16K ﹤0.01%
132
– –
IPG
428
DELISTED
Interpublic Group of Companies
IPG
$15K ﹤0.01%
472
-1,226
-72% -$39.2K
VMW
429
DELISTED
VMware, Inc
VMW
$10K ﹤0.01%
64
-252
-80% -$40.3K
AAP icon
430
Advance Auto Parts
AAP
$3.21B
$9K ﹤0.01%
42
-202
-83% -$39.6K
GDDY icon
431
GoDaddy
GDDY
$12.5B
$9K ﹤0.01%
106
-453
-81% -$37.8K
AVLR
432
DELISTED
Avalara, Inc.
AVLR
$5K ﹤0.01%
33
-257
-89% -$35.8K
ALV icon
433
Autoliv
ALV
$9B
$1K ﹤0.01%
12
-403
-97% -$40.6K
COF icon
434
Capital One
COF
$129B
– –
-177
Closed -$23K
FSLR icon
435
First Solar
FSLR
$22.3B
– –
-1,567
Closed -$137K
HIG icon
436
Hartford Financial Services
HIG
$38.7B
– –
-1,221
Closed -$82K
MGM icon
437
MGM Resorts International
MGM
$11.9B
– –
-1,365
Closed -$52K
NTRA icon
438
Natera
NTRA
$37.8B
– –
-375
Closed -$38K
PENN icon
439
PENN Entertainment
PENN
$2.78B
– –
-533
Closed -$56K
PHM icon
440
Pultegroup
PHM
$24.3B
– –
-886
Closed -$46K
ROL icon
441
Rollins
ROL
$22B
– –
-873
Closed -$30K
SRPT icon
442
Sarepta Therapeutics
SRPT
$1.84B
– –
-371,107
Closed -$27.7M
TRI icon
443
Thomson Reuters
TRI
$42.3B
– –
-2,157
Closed -$199K
TRMB icon
444
Trimble
TRMB
$12.5B
– –
-217
Closed -$17K
TTD icon
445
Trade Desk
TTD
$8.73B
– –
-620
Closed -$40K
UHAL icon
446
U-Haul Holding Co
UHAL
$14.1B
– –
-760
Closed -$47K
WDC icon
447
Western Digital
WDC
$160B
– –
-970
Closed -$49K
WHR icon
448
Whirlpool
WHR
$2.54B
– –
-212
Closed -$47K
NVTA
449
DELISTED
Invitae Corporation
NVTA
– –
-616
Closed -$24K
MRTX
450
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-160
Closed -$27K
15 16 17
18
19

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.